Blueprint Medicines Corp (BPMC) Dividend History
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. Its drug candidates include BLU-285, BLU 554, and BLU-667.
Last update 12/11/2023
Dividend Yield Summary
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
| Dividends | - | - | - | - | - | - |
| Average Price | 79.49 | 78.75 | 97.29 | 60.61 | 51.58 | - |
| Yield | - | - | - | - | - | - |
Dividend History
No history of dividends
| Date | Amount Per Share | Note |